azides has been researched along with vidarabine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boudinot, FD; Chu, CK; Cretton-Scott, E; Kotra, LP; Koudriakova, T; Manouilov, KK; Schinazi, RF; Shanmuganathan, K; Sommadossi, JP | 1 |
| Boudinot, FD; Chu, CK; Cretton-Scott, E; Kotra, LP; Manouilov, KK; Schinazi, RF; Sommadossi, JP | 1 |
2 other study(ies) available for azides and vidarabine
| Article | Year |
|---|---|
In vitro and in vivo evaluation of 6-azido-2',3'-dideoxy-2'-fluoro-beta-D-arabinofuranosylpurine and N6-methyl-2',3'-dideoxy-2'-fluoro-beta-D-arabinofuranosyladenine as prodrugs of the anti-HIV nucleosides 2'-F-ara-ddA and 2'-F-ara-ddI.
Topics: Animals; Anti-HIV Agents; Azides; Biotransformation; Didanosine; Dideoxyadenosine; Female; Magnetic Resonance Spectroscopy; Mice; Microsomes, Liver; Prodrugs; Spectrophotometry, Ultraviolet; Vidarabine | 1996 |
Synthesis, biotransformation, and pharmacokinetic studies of 9-(beta-D-arabinofuranosyl)-6-azidopurine: a prodrug for ara-A designed to utilize the azide reduction pathway.
Topics: Animals; Antiviral Agents; Area Under Curve; Azides; Biotransformation; Brain; Female; Mice; Oxidation-Reduction; Prodrugs; Tissue Distribution; Vidarabine | 1996 |